Cytoplasmic DNA sensing boosts CD4⁺ T cell metabolism for inflammatory induction

Abstract

DNA accumulation is associated with the development of autoimmune inflammatory diseases. However, the pathological role and underlying mechanism of cytoplasmic DNA accumulation in CD4⁺ T cells have not been well established. Here, we show that Trex1 deficiency-induced endogenous DNA accumulation in CD4⁺ T cells greatly promoted their induction of autoimmune inflammation in a lupus-like mouse model. Mechanistically, the accumulated DNA in CD4⁺ T cells was sensed by the KU complex, then triggered the activation of DNA-PKcs and ZAK and further facilitated the activation of AKT, which exacerbated glycolysis, thereby promoting the inflammatory responses. Accordingly, blocking the DNA sensing pathway in CD4⁺ T cells by genetic knockout of Zak or using our newly developed ZAK inhibitor iZAK2 attenuated all pathogenic characteristics in a lupus-like inflammation mouse model induced with Trex1-deficient CD4⁺ T cells. Overall, our study demonstrated a causal link between DNA-sensing and metabolic reprogramming in CD4⁺ T cells for inflammatory induction and suggested inhibition of the DNA sensing pathway may be a potential therapy for the treatment of inflammatory diseases.

Keywords

CD4⁺ T / DNA sensing / glycolysis / inflammation / autoimmunity disease

References

[1] Theofilopoulos AN, Kono DH, Baccala R. The multiple pathways to autoimmunity. Nat Immunol 2017;18:716–24.

[2] Crowl JT, Gray EE, Pestal K, et al. Intracellular nucleic acid detection in autoimmunity. Annu Rev Immunol 2017;35:313–36.

[3] Lehtinen DA, Harvey S, Mulcahy MJ, et al. The TREX1 double- stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease. J Biol Chem 2008;283:31649–56.

[4] Crow YJ, Chase DS, Lowenstein Schmidt J, et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A 2015;167A:296–312.

[5] Lee-Kirsch MA, Gong M, Chowdhury D, et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007;39:1065–7.

[6] Li Y, Shen Y, Jin K, et al. The DNA repair nuclease MRE11A functions as a mitochondrial protector and prevents T cell pyroptosis and tissue inflammation. Cell Metab 2019;30:477–492.e6.

[7] Melki I, Allaeys I, Tessandier N, et al. Platelets release mitochondrial antigens in systemic lupus erythematosus. Sci Transl Med 2021;13:eaav5928.

[8] Ablasser A, Chen ZJ. cGAS in action: expanding roles in immunity and inflammation. Science 2019;363:eaat8657.

[9] Gao D, Li T, Li X-D, et al. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proc Natl Acad Sci U S A 2015;112:E5699–5705.

[10] Roers A, Hiller B, Hornung V. Recognition of endogenous nucleic acids by the innate immune system. Immunity 2016;44:739–54.

[11] Dai J, Huang Y-J, He X, et al. Acetylation blocks cGAS activity and inhibits self-DNA-induced autoimmunity. Cell 2019;176:1447–1460.e14.

[12] Perrino FW, Harvey S, Shaban NM, et al. RNaseH2 mutants that cause Aicardi-Goutieres syndrome are active nucleases. J Mol Med (Berl) 2009;87:25–30.

[13] Reijns MA, Rabe B, Rigby RE, et al. Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell 2012;149:1008–22.

[14] Tan EM, Kunkel HG. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 1966;96:464–71.

[15] Duvvuri B, Lood C. Cell-free DNA as a biomarker in autoimmune rheumatic diseases. Front Immunol 2019;10:502.

[16] Courtney PA, Crockard AD, Williamson K, et al. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999;58:309–14.

[17] Lood C, Blanco LP, Purmalek MM, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med 2016;22:146–53.

[18] Mobarrez F, Vikerfors A, Gustafsson JT, et al. Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations. Sci Rep 2016;6:36025.

[19] Leadbetter EA, Rifkin IR, Hohlbaum AM, et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416:603–7.

[20] Wang Y, Fu Z, Li X, et al. Cytoplasmic DNA sensing by KU complex in aged CD4(+) T cell potentiates T cell activation and aging-related autoimmune inflammation. Immunity 2021;54:632–647.e9.

[21] O’Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol 2016;16:553–65.

[22] Geltink RIK, Kyle RL, Pearce EL. Unraveling the complex interplay between T cell metabolism and function. Annu Rev Immunol 2018;36:461–88.

[23] Morel L. Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol 2017;13:280–90.

[24] Weyand CM, Goronzy JJ. Immunometabolism in early and late stages of rheumatoid arthritis. Nat Rev Rheumatol 2017;13:291–301.

[25] Kolev M, Dimeloe S, Le Friec G, et al. Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses. Immunity 2015;42:1033–47.

[26] Macintyre AN, Gerriets VA, Nichols AG, et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab 2014;20:61–72.

[27] Hochrein SM, Wu H, Eckstein M, et al. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab 2022;34:516–532.e11.

[28] Yin Y et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med 2015;7:274ra218.

[29] Yin Y, Choi S-C, Xu Z, et al. Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus. J Immunol 2016;196:80–90.

[30] Li W, Qu G, Choi S-C, et al. Targeting T cell activation and lupus autoimmune phenotypes by inhibiting glucose transporters. Front Immunol 2019;10:833.

[31] Yang YG, Lindahl T, Barnes DE. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 2007;131:873–86.

[32] Grieves JL, Fye JM, Harvey S, et al. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease. Proc Natl Acad Sci U S A 2015;112:5117–22.

[33] Sharabi A, Tsokos GC. T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy. Nat Rev Rheumatol 2020;16:100–12.

[34] Klarquist J, Janssen EM. The bm12 inducible model of systemic lupus erythematosus (SLE) in C57BL/6 mice. J Vis Exp 2015;105:e53319.

[35] Liu J, Huang X, Hao S, et al. Peli1 negatively regulates noncanonical NF-kappaB signaling to restrain systemic lupus erythematosus. Nat Commun 2018;9:1136.

[36] Wofford JA, Wieman HL, Jacobs SR, et al. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 2008;111:2101–11.

[37] Crompton JG, Sukumar M, Restifo NP. Targeting Akt in cell transfer immunotherapy for cancer. Oncoimmunology 2016;5:e1014776.

[38] Jacobs SR, Herman CE, Maciver NJ, et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 2008;180:4476–86.

[39] Crow YJ, Leitch A, Hayward BE, et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 2006;38:910–6.

[40] Maelfait J, Bridgeman A, Benlahrech A, et al. Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1. Cell Rep 2016;16:1492–501.

[41] Gray EE, Treuting PM, Woodward JJ, et al. Cutting edge: cGAS is required for lethal autoimmune disease in the trex1-deficient mouse model of Aicardi-Goutieres syndrome. J Immunol 2015;195:1939–43.

[42] Sisirak V, Sally B, D’Agati V, et al. Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell 2016;166:88–101.

[43] Marshak-Rothstein A, Rifkin IR. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 2007;25:419–41.

[44] Liddicoat BJ, Piskol R, Chalk AM, et al. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 2015;349:1115–20.

[45] Hartner JC, Walkley CR, Lu J, et al. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol 2009;10:109–15.

[46] Chen C, Xu P. Cellular functions of cGAS-STING signaling. Trends Cell Biol 2022.

[47] Matsumoto Y. Development and evolution of DNA-dependent protein kinase inhibitors toward cancer therapy. Int J Mol Sci 2022;23:4264.

[48] Chen S, Lees-Miller JP, He Y, et al. Structural insights into the role of DNA-PK as a master regulator in NHEJ. Genome Instab Dis 2021;2:195–210.

[49] Hasan M, Gonugunta VK, Dobbs N, et al. Chronic innate immune activation of TBK1 suppresses mTORC1 activity and dysregulates cellular metabolism. Proc Natl Acad Sci U S A 2017;114:746–51.

[50] Bozulic L, Surucu B, Hynx D, et al. PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol Cell 2008;30:203–13.

[51] Liu L, Dai X, Yin S, et al. DNA-PK promotes activation of the survival kinase AKT in response to DNA damage through an mTORC2-ECT2 pathway. Sci Signal 2022;15:eabh2290.

[52] Moller SH, Hsueh PC, Yu YR, et al. Metabolic programs tailor T cell immunity in viral infection, cancer, and aging. Cell Metab 2022;34:378–95.

[53] Yang Z et al. Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci Transl Med 2016;8:331ra338.

[54] Shen Y, Wen Z, Li Y, et al. Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells. Nat Immunol 2017;18:1025–34.

[55] Telang S, Clem BF, Klarer Alden C, et al. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation. J Transl Med 2012;10:95.

[56] Choi SC, Titov AA, Abboud G, et al. Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells. Nat Commun 2018;9:4369.

RIGHTS & PERMISSIONS

2023 The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.